Indigomed
2 known investors
Indigo is developing an implantable continuous multi-metabolite monitoring (CMM) sensor based on silicon photonics that measures metabolites such as glucose, ketone, and lactate in real time, with data shown via a smartphone app. The device targets chronic disease management, initially diabetes, with potential applications in chronic kidney disease, oncology, cardiovascular disease, and athletic performance.
Founders & leadership
DD
Danaë DelbekeCTO and Founder
Investors · 2
Frequently asked questions
- What does Indigomed do?
- Indigo is developing an implantable continuous multi-metabolite monitoring (CMM) sensor based on silicon photonics that measures metabolites such as glucose, ketone, and lactate in real time, with data shown via a smartphone app. The device targets chronic disease management, initially diabetes, with potential applications in chronic kidney disease, oncology, cardiovascular disease, and athletic performance.
- Who founded Indigomed?
- Indigomed was founded by Danaë Delbeke.
- Who are Indigomed's investors?
- Indigomed's investors include Fund+, imec.xpand.